Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
34
NREF Quote, Financials, Valuation and Earnings
Last price:
$15.71
Seasonality move
:
-1.28%
Day range:
$15.52 - $16.25
52-week range:
$12.63 - $18.09
Dividend yield:
12.58%
P/E ratio:
14.45x
P/S ratio:
18.98x
P/B ratio:
0.83x
Volume:
77.2K
Avg. volume:
45.5K
1-year change:
2.98%
Market cap:
$277.6M
Revenue:
$1.4M
EPS (TTM):
$1.10
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $18.3M | $19.5M | $34.8M | $13.5M | $1.4M | |
| Revenue Growth (YoY) | 370.58% | 6.65% | 78.28% | -61.1% | -89.58% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $4.9M | $6.4M | $7.2M | $9.2M | |
| Other Inc / (Exp) | -- | -$542K | $13.1M | -$20.2M | -$14.4M | |
| Operating Expenses | -- | $4.9M | $6.4M | $7.3M | $9.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $28.9M | $34.2M | $83.5M | $14.2M | $18.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | $34.2M | $83.5M | $14.2M | $18.7M | |
| Minority Interest in Earnings | -$28.9M | -$21.3M | -$40.4M | -$7.5M | -$4.8M | |
| Net Income to Common Excl Extra Items | -- | $12.8M | $43.1M | $6.7M | $14M | |
| Basic EPS (Cont. Ops) | -- | $2.13 | $6.00 | $0.22 | $0.60 | |
| Diluted EPS (Cont. Ops) | -- | $1.74 | $3.93 | $0.22 | $0.60 | |
| Weighted Average Basic Share | $5M | $5.2M | $6.6M | $14.7M | $17.2M | |
| Weighted Average Diluted Share | $5M | $18.6M | $20.4M | $22.5M | $23M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $48.4M | $55.5M | $113.2M | $54.5M | $70.3M | |
| Revenue (Reported) | $18.3M | $19.5M | $34.8M | $13.5M | $1.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $48.4M | $55.5M | $113.2M | $54.5M | $70.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.3M | $7M | -$1.8M | -$10.9M | $21.6M | |
| Revenue Growth (YoY) | 314.22% | 63.89% | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.6M | $2M | $1.7M | $2.5M | $2.2M | |
| Other Inc / (Exp) | -$200K | $1.7M | -$8.5M | -$15.7M | $6.5M | |
| Operating Expenses | $1.6M | $2M | $1.7M | $2.5M | $2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $11.5M | $25.2M | -$9.4M | -$17.1M | $23.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $11.5M | $25.2M | -$9.4M | -$17.1M | $23.3M | |
| Minority Interest in Earnings | -$7.8M | -$11.1M | $948K | $2.4M | -$3.9M | |
| Net Income to Common Excl Extra Items | $3.7M | $14.1M | -$8.4M | -$14.7M | $19.4M | |
| Basic EPS (Cont. Ops) | $0.54 | $1.93 | -$0.62 | -$0.90 | $0.92 | |
| Diluted EPS (Cont. Ops) | $0.52 | $1.17 | -$0.62 | -$0.90 | $0.74 | |
| Weighted Average Basic Share | $5.3M | $6.9M | $15M | $17.2M | $17.5M | |
| Weighted Average Diluted Share | $5.6M | $20.7M | $22.7M | $23.1M | $30.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $17.6M | $33M | $1.3M | -$3.9M | $34.4M | |
| Revenue (Reported) | $4.3M | $7M | -$1.8M | -$10.9M | $21.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $17.6M | $33M | $1.3M | -$3.9M | $34.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $13.9M | $26.8M | $41.6M | -$15M | $22.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.2M | $7.9M | $6.8M | $9M | $11.7M | |
| Other Inc / (Exp) | $247K | $4.6M | -$5.1M | -$23.6M | $7.4M | |
| Operating Expenses | $5.6M | $7.9M | $6.8M | $9M | $11.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $404K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.1M | $88.7M | $37.1M | -$1.2M | $38.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $6.1M | $88.7M | $37.1M | -$1.2M | $38.7M | |
| Minority Interest in Earnings | -$5.3M | -$48.8M | -$14.2M | -$2.3M | -$9.8M | |
| Net Income to Common Excl Extra Items | $784K | $40M | $22.9M | -$3.5M | $28.9M | |
| Basic EPS (Cont. Ops) | -$1.33 | $6.43 | $1.90 | -$0.45 | $1.31 | |
| Diluted EPS (Cont. Ops) | -$1.35 | $3.81 | $1.34 | -$0.45 | $1.10 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $21.1M | $117.3M | $73.6M | $49M | $85.6M | |
| Revenue (Reported) | $13.9M | $26.8M | $41.6M | -$15M | $22.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $21.1M | $117.3M | $73.6M | $49M | $85.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $12.8M | $20.1M | $27M | -$1.5M | $19.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.4M | $6.4M | $6.8M | $7.1M | $9.5M | |
| Other Inc / (Exp) | $101K | $5.2M | -$13M | -$16.4M | $5.5M | |
| Operating Expenses | $3.4M | $6.4M | $6.8M | $7.1M | $9.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $7.9M | $62.5M | $16.2M | $805K | $20.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $7.9M | $62.5M | $16.2M | $805K | $20.8M | |
| Minority Interest in Earnings | -$5.3M | -$32.7M | -$6.6M | -$1.4M | -$6.5M | |
| Net Income to Common Excl Extra Items | $2.7M | $29.8M | $9.6M | -$614K | $14.3M | |
| Basic EPS (Cont. Ops) | $0.32 | $4.64 | $0.54 | -$0.19 | $0.52 | |
| Diluted EPS (Cont. Ops) | $0.30 | $3.01 | $0.42 | -$0.19 | $0.31 | |
| Weighted Average Basic Share | $15.7M | $17.2M | $43.6M | $51.6M | $52.1M | |
| Weighted Average Diluted Share | $41.5M | $59.5M | $67.2M | $68.8M | $83.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $22.6M | $84.4M | $44.8M | $39.3M | $54.6M | |
| Revenue (Reported) | $12.8M | $20.1M | $27M | -$1.5M | $19.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $22.6M | $84.4M | $44.8M | $39.3M | $54.6M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $301.8K | $30.2M | $26.5M | $20M | $13.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $4.3M | $5.1M | $8.3M | $15.7M | $22M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4.6M | $35.3M | $34.8M | $46M | $46.2M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $40.5M | $44.6M | $58.5M | $110.6M | $114.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.8B | $6.2B | $8.5B | $8.2B | $7B | |
| Accounts Payable | -- | $2.3M | $4M | $8M | $8.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $163.8M | $290.3M | $339M | $311.7M | |
| Long-Term Debt | $2.4B | $5.6B | $7.7B | $7.3B | $6.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.4B | $5.8B | $8B | $7.6B | $6.6B | |
| Common Stock | -- | $66K | $108K | $187K | $188K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $10 | $128.2M | $238M | $384M | $347.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $347.7M | $275.7M | $268.7M | $161M | $89.6M | |
| Total Equity | $347.7M | $403.9M | $506.7M | $545M | $436.9M | |
| Total Liabilities and Equity | $2.8B | $6.2B | $8.5B | $8.2B | $7B | |
| Cash and Short Terms | $301.8K | $30.2M | $26.5M | $20M | $13.8M | |
| Total Debt | $2.4B | $5.6B | $7.7B | $7.3B | $6.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $18M | $22.2M | $22.1M | $11M | $34.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $6.8M | $6.4M | $13.7M | $21.5M | $32.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $24.8M | $28.7M | $46M | $42.8M | $67.5M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $41.5M | $49.3M | $117.3M | $98.7M | $116.7M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $6.2B | $8.3B | $8.3B | $6.9B | $5.7B | |
| Accounts Payable | $1.2M | $7.2M | $16.2M | $10.1M | $10.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $161.4M | $229.8M | $367.3M | $308.1M | $249.9M | |
| Long-Term Debt | $5.6B | $7.6B | $7.4B | $6.1B | $4.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.8B | $7.8B | $7.8B | $6.5B | $5.3B | |
| Common Stock | $69K | $108K | $166K | $188K | $190K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -$54.4M | -$3K | $11.5M | -- | $41.5M | |
| Minority Interest, Total | $265.2M | $266.2M | $143.3M | $89.2M | $89.5M | |
| Total Equity | $389M | $496.5M | $495.1M | $434.2M | $422.1M | |
| Total Liabilities and Equity | $6.2B | $8.3B | $8.3B | $6.9B | $5.7B | |
| Cash and Short Terms | $18M | $22.2M | $22.1M | $11M | $34.7M | |
| Total Debt | $5.6B | $7.6B | $7.4B | $6.1B | $4.9B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $34.2M | $83.5M | $14.2M | $18.7M | |
| Depreciation & Amoritzation | -- | -- | -- | $2.9M | $2.5M | |
| Stock-Based Compensation | -- | $548K | $2M | $3.3M | $4.4M | |
| Change in Accounts Receivable | -- | -$6.7M | -$2.9M | -$10.7M | -$4.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $32.9M | $49.3M | $65.8M | $31.6M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$68.3M | $517.9M | $950.6M | $741.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -$8.3M | -$17.7M | -$33.2M | -$51.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $344.3M | $306.7M | $315.9M | $69.2M | |
| Long-Term Debt Repaid | -- | -$191.2M | -$103.5M | -$244.1M | -$121.1M | |
| Repurchase of Common Stock | -- | -$13.4M | -- | -- | -- | |
| Other Financing Activities | -- | -$200.2M | -$836.2M | -$1.2B | -$681.8M | |
| Cash From Financing | -- | $68.8M | -$567.4M | -$1B | -$776.6M | |
| Beginning Cash (CF) | -- | -- | $33.5M | $33.2M | $20.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $33.5M | -$239K | -$12.9M | -$3.7M | |
| Ending Cash (CF) | -- | $33.5M | $33.2M | $20.3M | $16.6M | |
| Levered Free Cash Flow | -- | $32.9M | $49.3M | $65.8M | $31.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $11.5M | $25.2M | -$9.4M | -$17.1M | $23.3M | |
| Depreciation & Amoritzation | -- | -- | $545K | $476K | $1.1M | |
| Stock-Based Compensation | $253K | $538K | $870K | $1.3M | $1.4M | |
| Change in Accounts Receivable | -$877K | -$372K | -$5.6M | -$1.6M | $2.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9.1M | $14.4M | $8.1M | $6M | $14.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$88.7M | $151.5M | $141.6M | $208.1M | $138.9M | |
| Dividends Paid (Ex Special Dividend) | -$2.1M | -$5.2M | -$8.4M | -$12.7M | -$11.1M | |
| Special Dividend Paid | -- | -- | -- | $185K | -- | |
| Long-Term Debt Issued | $186.3M | $49M | $59.5M | $188K | $37M | |
| Long-Term Debt Repaid | -$86.8M | -$23.9M | -$48.5M | -$36.2M | -$82.8M | |
| Repurchase of Common Stock | -$8.9M | -- | -$113.5M | -- | -- | |
| Other Financing Activities | -$37.4M | -$267.8M | -$69.2M | -$174M | -$106.9M | |
| Cash From Financing | $96.6M | -$172M | -$179.6M | -$222.7M | -$122.3M | |
| Beginning Cash (CF) | $966K | $30.7M | $61.1M | $21.6M | $7.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $17M | -$6.1M | -$29.9M | -$8.7M | $31.4M | |
| Ending Cash (CF) | $18M | $24.6M | $31.2M | $12.9M | $38.7M | |
| Levered Free Cash Flow | $9.1M | $14.4M | $8.1M | $6M | $14.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.1M | $88.7M | $37.1M | -$1.2M | $38.7M | |
| Depreciation & Amoritzation | -- | -- | $2.4M | $1.9M | $5.5M | |
| Stock-Based Compensation | $300K | $1.7M | $3M | $4.3M | $5.7M | |
| Change in Accounts Receivable | -$5.3M | -$3.2M | -$9.1M | -$6.4M | -$9.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $20.9M | $49.1M | $70.9M | $35.4M | $28.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -$5M | $5M | |
| Cash From Investing | -$110.2M | $238.4M | $1B | $876.9M | $837.8M | |
| Dividends Paid (Ex Special Dividend) | -$5.5M | -$15.3M | -$30M | -$46.4M | -$45.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $246.4M | $246.5M | $465.9M | $53M | $255.4M | |
| Long-Term Debt Repaid | -$183M | -$58.1M | -$275.5M | -$111.2M | -$721M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$78.3M | -$534.8M | -$1.3B | -$982.5M | -$439.3M | |
| Cash From Financing | $106.9M | -$280.9M | -$1.1B | -$930.6M | -$840.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $17.6M | $6.6M | $6.6M | -$18.3M | $25.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $20.9M | $49.1M | $70.9M | $35.4M | $28.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.9M | $62.5M | $16.2M | $805K | $20.8M | |
| Depreciation & Amoritzation | -- | -- | $2.4M | $1.4M | $4.5M | |
| Stock-Based Compensation | $292K | $1.5M | $2.4M | $3.4M | $4.7M | |
| Change in Accounts Receivable | -$5.2M | -$1.7M | -$7.9M | -$3.7M | -$8.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $21M | $37.2M | $58.8M | $28.4M | $24.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -$5M | -- | |
| Cash From Investing | -$110.1M | $196.5M | $713.2M | $639.5M | $735.9M | |
| Dividends Paid (Ex Special Dividend) | -$5.4M | -$12.4M | -$24.8M | -$38M | -$32.4M | |
| Special Dividend Paid | -- | -- | -- | $555K | -- | |
| Long-Term Debt Issued | $246.4M | $148.6M | $307.8M | $44.9M | $231.1M | |
| Long-Term Debt Repaid | -$183M | -$49.9M | -$221.8M | -$88.9M | -$688.8M | |
| Repurchase of Common Stock | -$10.3M | -- | -$113.5M | -- | -- | |
| Other Financing Activities | -$78.3M | -$412.8M | -$846.7M | -$593.3M | -$350.8M | |
| Cash From Financing | $107M | -$242.7M | -$774M | -$675.3M | -$738.8M | |
| Beginning Cash (CF) | $1.2M | $79.6M | $136.5M | $82.3M | $43.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $18M | -$8.9M | -$2.1M | -$7.4M | $22.1M | |
| Ending Cash (CF) | $19.1M | $70.7M | $134.4M | $74.8M | $65.3M | |
| Levered Free Cash Flow | $21M | $37.2M | $58.8M | $28.4M | $24.9M | |
Get NREF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NREF
Sector
P/E ratio
14.45x
12.02x
PEG ratio
-0.13x
0.36x
P/B ratio
0.83x
1.05x
Price / LTM sales
18.98x
2.55x
Growth Metrics
NREF
Sector
Revenue growth
33.91%
6.08%
Earnings growth
21.21%
6.45%
Revenue (5-year growth)
-18.36%
5.85%
Earnings forecast
$0.48
$0.56
Profitability
NREF
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
0.46%
5.27%
Return on assets
0.44%
0.98%
Return on equity
6.83%
9.43%
Earnings Date
Last Earnings Date
Oct
31
Next Earnings Date
Feb
28
Estimated Next Earnings Date
Jan
30
Balance Sheet
NREF
Sector
Total cash
$34.7M
$617M
Short term investments
--
$408.4M
Total assets
$7B
$4.5B
Long term debt
$4.9B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.8% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.65% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.96% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
